Theranostic Readiness: Preparing your Department

Theranostic Readiness: Preparing Your Department to Administer Novel Therapies
July 20, 2021 | 7:00 pm ET

The SNMMI Industry Partners Webinar Series provides a forum for industry partners to directly address the nuclear medicine and molecular imaging community.

Presented by 

This webinar is being hosted by Cardinal Health.
Please use the button to the left to register
 for this webinar.

The evolution of nuclear medicine now enables clinicians the ability to offer patients increasingly customized personalized care. Theranostic pairs of radiopharmaceuticals typify this change. Diagnostic radiopharmaceuticals can assist physicians in diagnosing or staging a disease. Following this, physicians can then customize a treatment plan using a therapeutic variant of the same radiopharmaceuticals with identical mechanisms of localization. Due to the complex regulatory and operational considerations involved in using theranostic radiopharmaceuticals, a multidisciplinary approach is warranted when establishing a program. Theranostic programs frequently involve infrastructure and radioactive material license changes.

Learning Objectives:

  • Define theranostic nuclear medicine and review its historical perspective and current applications.
  • Discuss opportunities and challenges associated with handling theranostic radiopharmaceuticals.
  • Discuss key operational considerations when establishing a theranostic program.
  • Discuss several regulatory considerations when establishing a theranostic program including: RAM licensing, equipment, shielding, and facility requirements.

CE Information
VOICE / Technologist: 1.0 CEH. CA Scope 1.0 (T) Therapy

This webinar is being hosted by Cardinal Health.
Please use the button to the left to register for this webinar.


When
7/20/2021 7:00 PM - 8:00 PM
 

Register for Another Webinar

Sign In to Register